How to treat a patient with psoriatic arthritis and chronic lymphocytic leukemia?
A 76-year-old male patient who has been suffering from psoriatic arthritis (PsA) for 15 years was diagnosed with chronic lymphocytic leukemia (CLL) 18 months ago. He has been treated him with a Bruton’s tyrosine kinase (BTK) inhibitor (ibrutinib) at a dose of 420 mg once daily (q.d.) for his CLL. Fo...
Saved in:
| Main Authors: | Jürgen Braun, Kirsten Karberg, Denis Poddubnyy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2024-06-01
|
| Series: | Exploration of Musculoskeletal Diseases |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A100751/100751.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ixekizumab in the treatment of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2024-12-01) -
Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01) -
Expression analysis of the IL-23/Th17 pathway in children with rhinovirus infection
by: Shu Teng, et al.
Published: (2025-07-01) -
PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)
by: O. A. Rumyantseva, et al.
Published: (2016-09-01) -
Research advances in functional roles of Th17 and IL-17 in acute kidney injury
by: Pang Hao-wen, et al.
Published: (2021-01-01)